Meningococcal vaccine (Menactra) is effective at preventing a very rare but highly deadly bacterial meningitis. An older version of this vaccine was previously given to some college students. The current vaccine came out in 2005 and is recommended for all children at age 11. A second dose is recommended between age 16 and 18. Side effects are minimal and rare and consist of occasional low grade fever and soreness at the injection site.